Lack of zinc finger protein 521 upregulates dopamine β-hydroxylase expression in the mouse brain, leading to abnormal behavior
Lack of zinc finger protein 521 upregulates dopamine β-hydroxylase expression in the mouse brain, leading to abnormal behavior
复制标题
DOI:
10.1016/j.lfs.2019.116559
复制
发表时间:
2019-08-15
期刊:
影响因子:
6.1
通讯作者:
Mitsuda, Noriaki
中科院分区:
文献类型:
--
作者:
Ohkubo, Nobutaka;Aoto, Mamoru;Mitsuda, Noriaki
Aim: Previously, we reported that mice deficient in most of the Zfp521 coding region (Zfp521(Delta/Delta) mice) displayed abnormal behaviors, including hyperlocomotion and lower anxiety. In this study, we aimed to elucidate the involvement and mechanisms of monoamine variation.Main methods: First, we compared the levels of dopamine (DA), noradrenaline (NA), and serotonin in the brains of Zfp521(Delta/Delta) and Zfp521(+/+) mice using enzyme-linked immunosorbent assay. Next, we elucidated the mechanisms using quantitative PCR and Western Blotting. Additionally, we administered inhibitory drug to the mice and performed behavioral tests.Key findings: Our results showed that the DA level decreased and the NA level increased in Zfp521(Delta/Delta)mice. We found that ZFP521 suppresses the expression of dopamine beta-hydroxylase (DBH), which converts DA into NA. We also demonstrated that paired homeodomain transcription factor 2 and early growth response protein-1, which are the transcription factors for Dbh, were involved in the upregulation of Dbh by ZFP521. The administration of nepicastat, a specific inhibitor of DBH, attenuated the abnormal behaviors of Zfp521(Delta/Delta) mice.Significance: These results suggest that the lack of ZFP521 upregulates the expression of DBH, which leads to a decrease in the DA level and an increase in the NA level in the brain, resulting in abnormal behaviors.